The role of FDG PET in the clinical management of head and neck cancer

Authors
Stokkel, MPM ten Broek, FW van Rijk, PP
Citation
Mpm. Stokkel et al., The role of FDG PET in the clinical management of head and neck cancer, ORAL ONCOL, 34(6), 1998, pp. 466-471
Citations number
63
Categorie Soggetti
Oncology
Journal title
ORAL ONCOLOGY
ISSN journal
13688375 → ACNP
Volume
34
Issue
6
Year of publication
1998
Pages
466 - 471
Database
ISI
SICI code
1368-8375(199811)34:6<466:TROFPI>2.0.ZU;2-P
Abstract
Positron emission tomography (PET) with fluorodeoxyglucose (FDG) allows the visualization of metabolic tissue activity. Use of FDG in in-vivo cancer i maging is based on enhanced glycolysis in tumor cells. In vivo experiments have demonstrated the potential use of FDG PET in squamous-cell head and ne ck tumors and the detection of tumor involvement in lymph nodes. Since its introduction in this area, several papers have appeared on the use of this imaging modality. Indications for the use of FDG PET in patients with head and neck cancer are discussed. (C) 1998 Elsevier Science Ltd. All rights re served.